Search Results
The anti-androgen drug Breezula is now being trialed for women with pattern hair loss. Today on November 13, 2019, the pharmaceutical company Cassiopea announced that a new phase 2 trial for female androgenic alopecia is soon to be underway. This announcement follows approval from the German BfArM (equivalent to the US FDA) to begin the…
Read MoreToday, Cassiopea SpA has announced topline data from its fully completed phase 2 dose ranging trial for men with androgenic alopecia. The results of the trial were favorable. Phase 2 Trial for Clascoterone The trial which was completed by Cassiopea included 400 men and 4 different doses of clascoterone, also known as breezula, for the…
Read MoreThings are heating up. Cassiopea SpA issued a press release today announcing “very positive” interim analysis phase 2 results for Breezula in the treatment of androgenic alopecia. Breezula is a topical anti-androgen and also known as Clascoterone. Here are some significant details I found while reading the release: The trial comprises 404 subjects and is…
Read MoreKintor Pharmaceuticals has announced that its proteolysis targeting chimera (PROTAC) drug GT20029 has reached its primary endpoint in its Phase 2 trial in China. GT20029 is a topical PROTAC targeted toward AGA. What are PROTACs? PROTACs are a novel class of heterobifunctional molecules that can induce the degradation of target proteins by hijacking the cell’s…
Read MoreThings are really heating up in the hair loss treatment industry on the first day of Summer 2023. Let’s take a look at all pertinent information and happenings in the AGA clinical trial world below. Cosmo Pharma Lists Phase 3 Trial On ClinicalTrials.gov A trial which was once highly anticipated, then questioned if it would…
Read MoreFollicle Thought is pleased to announce a new company developing a treatment for androgenetic alopecia with an innovative technology. Unlike most other biotechs tackling the challenging field of hair regeneration, StimuSIL is a biomedical device company. Their team has created a completely new way to deliver photobiomodulation and incorporated it into a proprietary, patented hair…
Read MoreTH16 Release Update (2/25/21) As mentioned, the all-natural OTC hair growth product TH16 by Triple Hair was slated to be released in Q1 2021. Not very unsurprisingly, it seems that the projected timeframe will have a slight delay. Today, I heard back from Attila Hajdu, Triple Hair VP of Business Development, who was able to…
Read MoreIn this article we will take a look at the most promising developments slated to occur in the hair restoration industry in 2020. Clinical Treatments And Drugs For Hair Loss In 2020 TissUse & J Hewitt – TissUse’s hair regeneration therapy is known as the Smart Hair Transplant or SHT which has been in development…
Read MoreIt’s always pleasing to learn of new companies who are developing drugs to treat hair loss. The more companies there are in the pipeline, the greater the chances are for success. Kintor Pharmaceuticals of China is the latest company to enter the global pharma market of alopecia treatments. Kintor Pharmaceuticals Pipeline There are two listed…
Read MoreThis article is a news feed containing brief updates of the most important hair growth treatment and hair loss cure news. It’s updated several times a week.
Read More